Pharma Cos. Seek To Toss Blood Pressure Drug Antitrust Suit

Law360, New York (March 13, 2017, 8:38 PM EDT) -- Mylan, Teva Pharmaceuticals and other generic-drug manufacturers on Friday slammed antitrust claims brought by drug buyers in New York federal court over an alleged conspiracy to jack up the price of generic blood pressure medication propranolol, arguing that the buyers haven’t plausibly shown there was a price-fixing conspiracy.

The drugmakers said that the direct purchaser plaintiffs’ consolidated amended complaint, even after weeks of fact-finding efforts, still fail to support their claim that the companies developed a price-fixing scheme around propranolol. The new complaint has charts and graphs...
To view the full article, register now.